 | • レポートコード：MRC2-11QY00967 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は婦人科がん治療薬のグローバル市場について調査・分析したレポートです。種類別（アルキル化剤、植物アルカロイド、アントラサイクリン、抗腫瘍抗生物質、その他）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別婦人科がん治療薬の競争状況、市場シェア ・世界の婦人科がん治療薬市場：種類別市場規模 2015年-2020年（アルキル化剤、植物アルカロイド、アントラサイクリン、抗腫瘍抗生物質、その他） ・世界の婦人科がん治療薬市場：種類別市場規模予測 2021年-2026年（アルキル化剤、植物アルカロイド、アントラサイクリン、抗腫瘍抗生物質、その他） ・世界の婦人科がん治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース） ・世界の婦人科がん治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース） ・北米の婦人科がん治療薬市場分析：米国、カナダ ・ヨーロッパの婦人科がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの婦人科がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の婦人科がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの婦人科がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Holdings、AstraZeneca、Sanofi、Eli Lilly、Pfizer、Takeda Pharmaceuticals、Bristol-Myers Squibb、Merck、Dr Reddy’s Laboratories、Johnson & Johnson、GlaxoSmithKline、Apotex、Hoffmann-La Roche、Novartis、Pfizer、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gynaecological cancers are being diagnosed among women on a large scale and are also emerging as one of the leading causes of death in various regions.
The surge of innovation in gynaecological cancer treatments is attracting all the major participants in the market for cancer drugs. Scientific advances are leading to the new treatment options in the market. Hence, the gynaecological cancer drugs market is also expected to see a significant growth in the coming years.
Market Analysis and Insights: Global Gynaecological Cancer Drugs Market
The global Gynaecological Cancer Drugs market size is projected to reach US$ 6549.3 million by 2026, from US$ 6324.5 million in 2020, at a CAGR of 3.3%% during 2021-2026.
Global Gynaecological Cancer Drugs Scope and Market Size
Gynaecological Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gynaecological Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gynaecological Cancer Drugs market is segmented into
Alkylating Agent
Plant Alkaloid
Anthracyclines
Antitumor Antibiotic
Others
Segment by Application, the Gynaecological Cancer Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
E-commerce
Regional and Country-level Analysis
The Gynaecological Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gynaecological Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gynaecological Cancer Drugs Market Share Analysis
Gynaecological Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gynaecological Cancer Drugs business, the date to enter into the Gynaecological Cancer Drugs market, Gynaecological Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche Holdings
AstraZeneca
Sanofi
Eli Lilly
Pfizer
Takeda Pharmaceuticals
Bristol-Myers Squibb
Merck
Dr Reddy’s Laboratories
Johnson & Johnson
GlaxoSmithKline
Apotex
Hoffmann-La Roche
Novartis
Pfizer
Teva Pharmaceutical
1 Study Coverage
1.1 Gynaecological Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Gynaecological Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gynaecological Cancer Drugs Market Size Growth Rate by Type
1.4.2 Alkylating Agent
1.4.3 Plant Alkaloid
1.4.4 Anthracyclines
1.4.5 Antitumor Antibiotic
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gynaecological Cancer Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gynaecological Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gynaecological Cancer Drugs Revenue 2015-2026
2.1.2 Global Gynaecological Cancer Drugs Sales 2015-2026
2.2 Global Gynaecological Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gynaecological Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gynaecological Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gynaecological Cancer Drugs Competitor Landscape by Players
3.1 Gynaecological Cancer Drugs Sales by Manufacturers
3.1.1 Gynaecological Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Gynaecological Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Gynaecological Cancer Drugs Revenue by Manufacturers
3.2.1 Gynaecological Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Gynaecological Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gynaecological Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gynaecological Cancer Drugs Revenue in 2019
3.2.5 Global Gynaecological Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gynaecological Cancer Drugs Price by Manufacturers
3.4 Gynaecological Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gynaecological Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gynaecological Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gynaecological Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gynaecological Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Gynaecological Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Gynaecological Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Gynaecological Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gynaecological Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gynaecological Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gynaecological Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gynaecological Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gynaecological Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gynaecological Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Gynaecological Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Gynaecological Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Gynaecological Cancer Drugs Price by Application (2015-2020)
5.2 Gynaecological Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gynaecological Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gynaecological Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gynaecological Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gynaecological Cancer Drugs by Country
6.1.1 North America Gynaecological Cancer Drugs Sales by Country
6.1.2 North America Gynaecological Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gynaecological Cancer Drugs Market Facts & Figures by Type
6.3 North America Gynaecological Cancer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Gynaecological Cancer Drugs by Country
7.1.1 Europe Gynaecological Cancer Drugs Sales by Country
7.1.2 Europe Gynaecological Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gynaecological Cancer Drugs Market Facts & Figures by Type
7.3 Europe Gynaecological Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gynaecological Cancer Drugs by Region
8.1.1 Asia Pacific Gynaecological Cancer Drugs Sales by Region
8.1.2 Asia Pacific Gynaecological Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gynaecological Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Gynaecological Cancer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gynaecological Cancer Drugs by Country
9.1.1 Latin America Gynaecological Cancer Drugs Sales by Country
9.1.2 Latin America Gynaecological Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gynaecological Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Gynaecological Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gynaecological Cancer Drugs by Country
10.1.1 Middle East and Africa Gynaecological Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Gynaecological Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gynaecological Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Gynaecological Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Corporation Information
11.1.2 Roche Holdings Description and Business Overview
11.1.3 Roche Holdings Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Holdings Gynaecological Cancer Drugs Products Offered
11.1.5 Roche Holdings Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Gynaecological Cancer Drugs Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Gynaecological Cancer Drugs Products Offered
11.3.5 Sanofi Related Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description and Business Overview
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Gynaecological Cancer Drugs Products Offered
11.4.5 Eli Lilly Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Gynaecological Cancer Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Corporation Information
11.6.2 Takeda Pharmaceuticals Description and Business Overview
11.6.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Pharmaceuticals Gynaecological Cancer Drugs Products Offered
11.6.5 Takeda Pharmaceuticals Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Gynaecological Cancer Drugs Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Description and Business Overview
11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Gynaecological Cancer Drugs Products Offered
11.8.5 Merck Related Developments
11.9 Dr Reddy’s Laboratories
11.9.1 Dr Reddy’s Laboratories Corporation Information
11.9.2 Dr Reddy’s Laboratories Description and Business Overview
11.9.3 Dr Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Products Offered
11.9.5 Dr Reddy’s Laboratories Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Gynaecological Cancer Drugs Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Roche Holdings
11.1.1 Roche Holdings Corporation Information
11.1.2 Roche Holdings Description and Business Overview
11.1.3 Roche Holdings Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Holdings Gynaecological Cancer Drugs Products Offered
11.1.5 Roche Holdings Related Developments
11.12 Apotex
11.12.1 Apotex Corporation Information
11.12.2 Apotex Description and Business Overview
11.12.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Apotex Products Offered
11.12.5 Apotex Related Developments
11.13 Hoffmann-La Roche
11.13.1 Hoffmann-La Roche Corporation Information
11.13.2 Hoffmann-La Roche Description and Business Overview
11.13.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hoffmann-La Roche Products Offered
11.13.5 Hoffmann-La Roche Related Developments
11.14 Novartis
11.14.1 Novartis Corporation Information
11.14.2 Novartis Description and Business Overview
11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Novartis Products Offered
11.14.5 Novartis Related Developments
11.15 Pfizer
11.15.1 Pfizer Corporation Information
11.15.2 Pfizer Description and Business Overview
11.15.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Pfizer Products Offered
11.15.5 Pfizer Related Developments
11.16 Teva Pharmaceutical
11.16.1 Teva Pharmaceutical Corporation Information
11.16.2 Teva Pharmaceutical Description and Business Overview
11.16.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Teva Pharmaceutical Products Offered
11.16.5 Teva Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gynaecological Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Gynaecological Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Gynaecological Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Gynaecological Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Gynaecological Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Gynaecological Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Gynaecological Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Gynaecological Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Gynaecological Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Gynaecological Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Gynaecological Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gynaecological Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gynaecological Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gynaecological Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gynaecological Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Gynaecological Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Gynaecological Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Gynaecological Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Gynaecological Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gynaecological Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gynaecological Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gynaecological Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gynaecological Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gynaecological Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gynaecological Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Gynaecological Cancer Drugs Market Segments
Table 2. Ranking of Global Top Gynaecological Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gynaecological Cancer Drugs Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Alkylating Agent
Table 5. Major Manufacturers of Plant Alkaloid
Table 6. Major Manufacturers of Anthracyclines
Table 7. Major Manufacturers of Antitumor Antibiotic
Table 8. Major Manufacturers of Others
Table 9. Global Gynaecological Cancer Drugs Market Size Growth Rate by Application 2020-2026 (Kg)
Table 10. Global Gynaecological Cancer Drugs Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 11. Global Gynaecological Cancer Drugs Sales by Regions 2015-2020 (Kg)
Table 12. Global Gynaecological Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Gynaecological Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Gynaecological Cancer Drugs Sales by Manufacturers (2015-2020) (Kg)
Table 15. Global Gynaecological Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Gynaecological Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Gynaecological Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynaecological Cancer Drugs as of 2019)
Table 18. Gynaecological Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Gynaecological Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Gynaecological Cancer Drugs Price (2015-2020) (USD/Kg)
Table 21. Gynaecological Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gynaecological Cancer Drugs Product Type
Table 23. Date of International Manufacturers Enter into Gynaecological Cancer Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 26. Global Gynaecological Cancer Drugs Sales Share by Type (2015-2020)
Table 27. Global Gynaecological Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Gynaecological Cancer Drugs Revenue Share by Type (2015-2020)
Table 29. Gynaecological Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 30. Global Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 31. Global Gynaecological Cancer Drugs Sales Share by Application (2015-2020)
Table 32. North America Gynaecological Cancer Drugs Sales by Country (2015-2020) (Kg)
Table 33. North America Gynaecological Cancer Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Gynaecological Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Gynaecological Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 37. North America Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 39. North America Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Gynaecological Cancer Drugs Sales by Country (2015-2020) (Kg)
Table 41. Europe Gynaecological Cancer Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Gynaecological Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Gynaecological Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 45. Europe Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 47. Europe Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Gynaecological Cancer Drugs Sales by Region (2015-2020) (Kg)
Table 49. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Gynaecological Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Gynaecological Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 53. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 55. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Gynaecological Cancer Drugs Sales by Country (2015-2020) (Kg)
Table 57. Latin America Gynaecological Cancer Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Gynaecological Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Gynaecological Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 61. Latin America Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 63. Latin America Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Gynaecological Cancer Drugs Sales by Country (2015-2020) (Kg)
Table 65. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Gynaecological Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Gynaecological Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Gynaecological Cancer Drugs Sales by Type (2015-2020) (Kg)
Table 69. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Gynaecological Cancer Drugs Sales by Application (2015-2020) (Kg)
Table 71. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Table 72. Roche Holdings Corporation Information
Table 73. Roche Holdings Description and Major Businesses
Table 74. Roche Holdings Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 75. Roche Holdings Product
Table 76. Roche Holdings Recent Development
Table 77. AstraZeneca Corporation Information
Table 78. AstraZeneca Description and Major Businesses
Table 79. AstraZeneca Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 80. AstraZeneca Product
Table 81. AstraZeneca Recent Development
Table 82. Sanofi Corporation Information
Table 83. Sanofi Description and Major Businesses
Table 84. Sanofi Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 85. Sanofi Product
Table 86. Sanofi Recent Development
Table 87. Eli Lilly Corporation Information
Table 88. Eli Lilly Description and Major Businesses
Table 89. Eli Lilly Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 90. Eli Lilly Product
Table 91. Eli Lilly Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Major Businesses
Table 94. Pfizer Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Takeda Pharmaceuticals Corporation Information
Table 98. Takeda Pharmaceuticals Description and Major Businesses
Table 99. Takeda Pharmaceuticals Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Takeda Pharmaceuticals Product
Table 101. Takeda Pharmaceuticals Recent Development
Table 102. Bristol-Myers Squibb Corporation Information
Table 103. Bristol-Myers Squibb Description and Major Businesses
Table 104. Bristol-Myers Squibb Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Bristol-Myers Squibb Product
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Merck Corporation Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Merck Product
Table 111. Merck Recent Development
Table 112. Dr Reddy’s Laboratories Corporation Information
Table 113. Dr Reddy’s Laboratories Description and Major Businesses
Table 114. Dr Reddy’s Laboratories Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Dr Reddy’s Laboratories Product
Table 116. Dr Reddy’s Laboratories Recent Development
Table 117. Johnson & Johnson Corporation Information
Table 118. Johnson & Johnson Description and Major Businesses
Table 119. Johnson & Johnson Gynaecological Cancer Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Johnson & Johnson Product
Table 121. Johnson & Johnson Recent Development
Table 122. GlaxoSmithKline Corporation Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. GlaxoSmithKline Product
Table 126. GlaxoSmithKline Recent Development
Table 127. Apotex Corporation Information
Table 128. Apotex Description and Major Businesses
Table 129. Apotex Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. Apotex Product
Table 131. Apotex Recent Development
Table 132. Hoffmann-La Roche Corporation Information
Table 133. Hoffmann-La Roche Description and Major Businesses
Table 134. Hoffmann-La Roche Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 135. Hoffmann-La Roche Product
Table 136. Hoffmann-La Roche Recent Development
Table 137. Novartis Corporation Information
Table 138. Novartis Description and Major Businesses
Table 139. Novartis Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 140. Novartis Product
Table 141. Novartis Recent Development
Table 142. Pfizer Corporation Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 145. Pfizer Product
Table 146. Pfizer Recent Development
Table 147. Teva Pharmaceutical Corporation Information
Table 148. Teva Pharmaceutical Description and Major Businesses
Table 149. Teva Pharmaceutical Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 150. Teva Pharmaceutical Product
Table 151. Teva Pharmaceutical Recent Development
Table 152. Global Gynaecological Cancer Drugs Sales Forecast by Regions (2021-2026) (Kg)
Table 153. Global Gynaecological Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 154. Global Gynaecological Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 155. Global Gynaecological Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 156. North America: Gynaecological Cancer Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 157. North America: Gynaecological Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Europe: Gynaecological Cancer Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 159. Europe: Gynaecological Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Asia Pacific: Gynaecological Cancer Drugs Sales Forecast by Region (2021-2026) (Kg)
Table 161. Asia Pacific: Gynaecological Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 162. Latin America: Gynaecological Cancer Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 163. Latin America: Gynaecological Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Middle East and Africa: Gynaecological Cancer Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 165. Middle East and Africa: Gynaecological Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 167. Key Challenges
Table 168. Market Risks
Table 169. Main Points Interviewed from Key Gynaecological Cancer Drugs Players
Table 170. Gynaecological Cancer Drugs Customers List
Table 171. Gynaecological Cancer Drugs Distributors List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Gynaecological Cancer Drugs Product Picture
Figure 2. Global Gynaecological Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Alkylating Agent Product Picture
Figure 4. Plant Alkaloid Product Picture
Figure 5. Anthracyclines Product Picture
Figure 6. Antitumor Antibiotic Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gynaecological Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. E-commerce
Figure 12. Gynaecological Cancer Drugs Report Years Considered
Figure 13. Global Gynaecological Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Gynaecological Cancer Drugs Sales 2015-2026 (Kg)
Figure 15. Global Gynaecological Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Gynaecological Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Gynaecological Cancer Drugs Sales Market Share by Region in 2019
Figure 18. Global Gynaecological Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Gynaecological Cancer Drugs Revenue Market Share by Region in 2019
Figure 20. Global Gynaecological Cancer Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Gynaecological Cancer Drugs Revenue in 2019
Figure 22. Gynaecological Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Gynaecological Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Gynaecological Cancer Drugs Sales Market Share by Type in 2019
Figure 25. Global Gynaecological Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Gynaecological Cancer Drugs Revenue Market Share by Type in 2019
Figure 27. Global Gynaecological Cancer Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Gynaecological Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Gynaecological Cancer Drugs Sales Market Share by Application in 2019
Figure 30. Global Gynaecological Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Gynaecological Cancer Drugs Revenue Market Share by Application in 2019
Figure 32. North America Gynaecological Cancer Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 33. North America Gynaecological Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Gynaecological Cancer Drugs Sales Market Share by Country in 2019
Figure 35. North America Gynaecological Cancer Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 37. U.S. Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 39. Canada Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Gynaecological Cancer Drugs Market Share by Type in 2019
Figure 41. North America Gynaecological Cancer Drugs Market Share by Application in 2019
Figure 42. Europe Gynaecological Cancer Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 43. Europe Gynaecological Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Gynaecological Cancer Drugs Sales Market Share by Country in 2019
Figure 45. Europe Gynaecological Cancer Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 47. Germany Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 49. France Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 51. U.K. Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 53. Italy Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 55. Russia Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Gynaecological Cancer Drugs Market Share by Type in 2019
Figure 57. Europe Gynaecological Cancer Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Gynaecological Cancer Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 59. Asia Pacific Gynaecological Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Gynaecological Cancer Drugs Revenue Market Share by Region in 2019
Figure 62. China Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 63. China Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 65. Japan Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 67. South Korea Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 69. India Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 71. Australia Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 73. Taiwan Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 75. Indonesia Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 77. Thailand Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 79. Malaysia Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 81. Philippines Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 83. Vietnam Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Gynaecological Cancer Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Gynaecological Cancer Drugs Market Share by Application in 2019
Figure 86. Latin America Gynaecological Cancer Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 87. Latin America Gynaecological Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Gynaecological Cancer Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Gynaecological Cancer Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 91. Mexico Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 93. Brazil Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 95. Argentina Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Gynaecological Cancer Drugs Market Share by Type in 2019
Figure 97. Latin America Gynaecological Cancer Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Gynaecological Cancer Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 99. Middle East and Africa Gynaecological Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Gynaecological Cancer Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 103. Turkey Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 105. Saudi Arabia Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Gynaecological Cancer Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 107. U.A.E Gynaecological Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Gynaecological Cancer Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Gynaecological Cancer Drugs Market Share by Application in 2019
Figure 110. North America Gynaecological Cancer Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 111. North America Gynaecological Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Gynaecological Cancer Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 113. Europe Gynaecological Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Gynaecological Cancer Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 115. Asia Pacific Gynaecological Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Gynaecological Cancer Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. Latin America Gynaecological Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Gynaecological Cancer Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Middle East and Africa Gynaecological Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…- 腫瘍学/がん治療薬の世界市場（～2026年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastroint…
- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…
- 尿管がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ureter Cancer Drugs Market The global Ureter Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ureter Cancer Drugs Scope and Market Size Ureter Cancer Drugs market is seg…
- 精巣腫瘍治療薬の世界市場（～2026年） Market Analysis and Insights: Global Testicular Cancer Drugs Market The global Testicular Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Testicular Cancer Drugs Scope and Market Size Testicular Cancer Dru…